SLRX

Salarius Pharmaceuticals, Inc.

Healthcare · USD

Set alert

Price alert · SLRX

All alert types
0.84 USD 0.00 0.00%
As of Jan 7, 2026 Extended hours 0.83 -1.18%
Bid
0.82 × 2
Ask
0.82 × 2
0.6865 Day range 0.8976

52-week range unavailable

YTD
+29.47%
1 year
-96.73%
Open
0.706
Prev close
0.84
Mkt cap
2.26M
Vol
5.96M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
0.6865
High
0.8976
Forward P/E
-0.17
Beta
0.93
Short ratio
0.08
Inst. own
0.36%
Dividend
0.00
Ex-div date
50-d avg
1.52
200-d avg
2.59
1y target
0.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for SLRX has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-15.54 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.0×
FY 2016: -2.2×FY 2017: -1.8×FY 2018: -0.3×FY 2019: -1.8×FY 2020: -1.8×FY 2021: -1.6×FY 2022: -0.1×FY 2023: -0.2×FY 2024: -0.3×FY 2025: -0.0×
FY 2016 5y median -0.2× FY 2025
P/S 0.0×
FY 2016: 426302×FY 2017: 237413×FY 2018: 35642×FY 2019: 3.6×FY 2020: 2.7×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.1×
FY 2016: 7263×FY 2017: 10396×FY 2018: 3218×FY 2019: 1.2×FY 2020: 0.6×FY 2021: 0.5×FY 2022: 0.3×FY 2023: 0.5×FY 2024: 1.2×FY 2025: 0.1×
FY 2016 5y median 0.5× FY 2025
P/FCF -0.1×
FY 2016: -13212×FY 2017: -10870×FY 2018: -1266×FY 2019: -1.1×FY 2020: -1.4×FY 2021: -2.0×FY 2022: -0.2×FY 2023: -0.2×FY 2024: -0.4×FY 2025: -0.1×
FY 2016 5y median -0.2× FY 2025
EV/EBITDA -1454×
FY 2016: -10877×FY 2017: -8795×FY 2018: -1367×FY 2019: -1.1×FY 2020: -0.5×FY 2021: 0.7×FY 2022: 0.4×FY 2023: 0.2×FY 2024: 0.1×FY 2025: -1454×
FY 2016 5y median 0.2× FY 2025
EV/Sales 0.0×
FY 2016: 426280×FY 2017: 237398×FY 2018: 35631×FY 2019: 2.6×FY 2020: 0.7×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -1544.9%
FY 2016: -0.0%FY 2017: -0.0%FY 2018: -0.1%FY 2019: -93.3%FY 2020: -72.4%FY 2021: -49.7%FY 2022: -552.5%FY 2023: -483.6%FY 2024: -254.3%FY 2025: -1544.9%
FY 2016 5y median -483.6% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 34.4%FY 2017: 60.3%FY 2018: 48.6%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: -3946.5%FY 2017: -2724.6%FY 2018: -2633.7%FY 2019: -238.5%FY 2020: -148.8%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: -3907.6%FY 2017: -2701.7%FY 2018: -2615.6%FY 2019: -200.2%FY 2020: -140.5%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -212.6%
FY 2016: -66.6%FY 2017: -118.3%FY 2018: -236.2%FY 2019: -65.6%FY 2020: -33.2%FY 2021: -33.0%FY 2022: -304.4%FY 2023: -237.2%FY 2024: -368.8%FY 2025: -212.6%
FY 2016 5y median -237.2% FY 2025
ROIC -214.2%
FY 2016: -67.2%FY 2017: -119.1%FY 2018: -410.8%FY 2019: -74.6%FY 2020: -34.4%FY 2021: -33.1%FY 2022: -306.6%FY 2023: -231.2%FY 2024: -330.8%FY 2025: -214.2%
FY 2016 5y median -231.2% FY 2025
ROA -113.2%
FY 2016: -62.5%FY 2017: -98.4%FY 2018: -211.0%FY 2019: -49.9%FY 2020: -29.5%FY 2021: -31.3%FY 2022: -215.7%FY 2023: -190.4%FY 2024: -184.4%FY 2025: -113.2%
FY 2016 5y median -184.4% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 26.1%FY 2018: -34.2%FY 2019: 313.4%FY 2020: 51.0%FY 2021: -100.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -120.0%
FY 2016: -36.5%FY 2017: 12.9%FY 2018: 36.4%FY 2019: 62.6%FY 2020: 5.8%FY 2021: -64.6%FY 2022: -148.5%FY 2023: 59.5%FY 2024: 55.5%FY 2025: -120.0%
FY 2016 FY 2025
EPS (diluted) 70.1%
FY 2016: -836.1%FY 2017: 18.1%FY 2018: 38.7%FY 2019: 93.0%FY 2020: 76.4%FY 2021: 38.0%FY 2022: -80.3%FY 2023: 78.0%FY 2024: 76.4%FY 2025: 70.1%
FY 2016 FY 2025
Free Cash Flow -6.7%
FY 2016: -55.2%FY 2017: 14.6%FY 2018: 15.2%FY 2019: 50.9%FY 2020: 10.9%FY 2021: 1.1%FY 2022: -87.2%FY 2023: 32.7%FY 2024: 64.8%FY 2025: -6.7%
FY 2016 FY 2025

Financial Health

Current Ratio 2.1×
FY 2016: 16.1×FY 2017: 5.9×FY 2018: 2.1×FY 2019: 1.4×FY 2020: 5.7×FY 2021: 14.3×FY 2022: 3.4×FY 2023: 5.0×FY 2024: 2.0×FY 2025: 2.1×
FY 2016 5y median 3.4× FY 2025
Quick Ratio 2.1×
FY 2016: 15.9×FY 2017: 5.8×FY 2018: 2.0×FY 2019: 1.4×FY 2020: 5.7×FY 2021: 14.3×FY 2022: 3.4×FY 2023: 5.0×FY 2024: 2.0×FY 2025: 2.1×
FY 2016 5y median 3.4× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -1498×
FY 2016: 0.6×FY 2017: 0.6×FY 2018: 0.4×FY 2019: 0.4×FY 2020: 1.4×FY 2021: 2.3×FY 2022: 0.5×FY 2023: 0.4×FY 2024: 0.4×FY 2025: -1498×
FY 2016 5y median 0.4× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -2555×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 1.1%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -1.9%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31